Texas A&M University researchers are pioneering the 3D printing of personalized pediatric medication doses, aiming to ...

D printing could allow multiple medications for patients to be combined into a single daily pill or 'polypill' ...

(NYSEA:IBIO) today reported financial results for the fiscal first quarter ended September 30, 2024 and provided a corporate ...

Achieving precision in 3D printing requires a reliable feedstock and distribution system. Learn about the key factors that ...

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment ...

The company also recommends the immediate fixing of critical issues in Adobe Substance 3D Painter, Adobe After Effects and ...

Report Ocean has published a new report on the 3D Cell Culture Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...

ONVO READ THE FULL ONVO RESEARCH REPORT Organovo Holdings (NASDAQ:ONVO) is a biotechnology company that is both a developer of 3D tissue technology that has the potential to change the way treatments ...

Irvine, CA – November 7, 2024 – Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced ...

Moore also wore black-and-white cap-toe pumps; she carried a salmon-colored clutch with a rose closure (it matched her floral ...

SimBioSys announced that it received its second FDA 510(k) clearance for TumorSight Viz to expand its use by breast surgeons ...

One day, doctors might be able to 3D print copies of your organs in order to test a variety of drugs, thanks to a new ...